Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Natalie Breytenbach
Observed name:
N Breytenbach
Institution:
United Therapeutics (United States)
Observed institution:
United Therapeutics (United States)
ORCID:
0000-0002-0545-6432
Observed ORCID:
0000-0002-0545-6432
OpenAlex ID:
A5054296338
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
2026
·
Steven D. Nathan
, Peter Smith
, et al.
·
New England Journal of Medicine
·
46
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
2026
·
Steven D. Nathan
, Peter Smith
, et al.
·
New England Journal of Medicine
·
24
Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary Fibrosis
2024
·
Steven D. Nathan
, Juergen Behr
, et al.
·
CHEST Pulmonary
·
10
PDF
TETON phase 3 clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis
2025
·
Steven D Nathan
, Juergen Behr
, et al.
·
European Respiratory Journal
·
3
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
2026
·
Steven D Nathan
, Peter Smith
, et al.
·
American Journal of Respiratory and Critical Care Medicine
PDF
A82-01 TETON-1 Phase 3 Clinical Trial Of Inhaled Treprostinil For The Treatment Of Idiopathic Pulmonary Fibrosis
2026
·
S D Nathan
, J Behr
, et al.
·
American Journal of Respiratory and Critical Care Medicine
C103-25 TETON-1 Phase 3 Clinical Trial of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
2026
·
S D Nathan
, J Behr
, et al.
·
American Journal of Respiratory and Critical Care Medicine
PDF
B95-09 TETON Phase 3 Clinical Trials of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis: Integrated Efficacy and Safety Results for TETON-1 and TETON-2
2026
·
S D Nathan
, J Behr
, et al.
·
American Journal of Respiratory and Critical Care Medicine
C103-16 TETON-PPF Clinical Trial of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis
2026
·
S D Nathan
, J Behr
, et al.
·
American Journal of Respiratory and Critical Care Medicine
TETON-PPF clinical trial of inhaled treprostinil for the treatment of progressive pulmonary fibrosis
2025
·
Steven D Nathan
, Juergen Behr
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
10
Citation count:
83
H-index:
3
I10-index:
3
Year
Topic
Type